Added to YB: 2025-05-27
Pitch date: 2025-05-25
1SXP.F [neutral]
SCHOTT Pharma AG & Co. KGaA
-46.9%
current return
Author Info
Octopus Value is a private investor focusing on quality companies with margin of safety Sign up for the newsletter.
Company Info
SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.
Market Cap
EUR 4.2B
Pitch Price
EUR 28.25
Price Target
N/A
Dividend
0.57%
EV/EBITDA
16.72
P/E
28.61
EV/Sales
4.62
Sector
Life Sciences Tools and Services
Category
growth
Schott Pharma AG - H1 Earnings Review
1SXP.F (earnings update): H1 2025 Rev +3.4% (€482M, +7% CC) with N.America sales +31.6% YoY. Q2 accelerated +8% vs Q1. Gross margin down to 33.2% due to mix, ramp-up costs. CapEx reduced as Serbia/Hungary factories now built. Strong customer diversification, no client >10% of rev. FCF €21.5M (-38%). Outlook unchanged despite strong start due to market volatility.
Read full article (7 min)